![](/img/cover-not-exists.png)
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts
Hajnalka Andrikovics, Sarolta Nahajevszky, Anikó Szilvási, András Bors, Emma Ádám, András Kozma, Béla Kajtár, Anikó Barta, Anna Poros, Attila TordaiVolume:
25
Year:
2007
Language:
english
Pages:
5
DOI:
10.1002/hon.822
File:
PDF, 108 KB
english, 2007